Home›Companies›Biotech & Pharma›Endurazymes

EnduraFAST Inc.

Develops technologies to help evaluate enzyme performance.

Updated Nov 9, 2026·Latest SEC filing Aug 17, 2026·Suggest an edit

About Endurazymes

Endurazymes is a private company based in The Villages, Florida, incorporated in 2026 in Wyoming. It has reported $50,000 raised in one offering on Form D since August 2026. Its chief executive is Andrew DeLuise.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 9, 2026Aug 17, 2026$50,000of $500K target2$25,000EquityRule 506(c)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Endurazymes's Form D filed Aug 17, 2026.

AF
Anthony Franklin
Chief Commercial Officer
Also a chief operating officer at StrataBio.
RL
Robert Long
Founder; Chief Strategy & Administration Officer, director
Also a chief strategy & administration officer, director at StrataBio.
CP
Corey Park
Founder; Principal Stockholder
Also a founder and strategic advisor at StrataBio.
AD
Andrew DeLuise
Founder; Chief Executive Officer; Director
Also an executive officer, director and promoter at StrataBio.
MK
Michael Kramer
Founder; Director
Also a chief executive officer & co-founder, director at StrataBio.
SL
Sophia Tremari Lombardo
Founder; Director
Also a director and promoter at StrataBio.
SW
Scott Warden
Chief Business Officer
Also an executive officer at StrataBio.

Sources

  1. SECEnduraFAST Inc. filing history
  2. PressEnduraFAST license announcement